barr 555 271 (Sulfinpyrazone 100 mg)
Pill imprint barr 555 271 has been identified as Sulfinpyrazone 100 mg.
Sulfinpyrazone is used in the treatment of gout; gouty arthritis and belongs to the drug class antigout agents. FDA has not classified the drug for risk during pregnancy. Sulfinpyrazone 100 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about sulfinpyrazone
- Side Effects
- During Pregnancy
- Drug Images
- Drug Interactions
- Support Group
- 1 Review – Add your own review/rating
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.